| Acne |
Yes |
| Active Half-Life |
1-1.5 days |
| Active substance |
Drostanolone Propionate |
| Also known as |
Dermovate, Clobex, Temovate, Olux |
| Aromatization |
No |
| Blood pressure |
Typically no effect on blood pressure when used topically |
| Chemical name |
21-chloro-9-fluoro-11-beta,17-dihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione 17-propionate |
| Classification |
Anabolic steroid |
| Dosage |
Men 300-700 mg/week |
| Dosage (medical) |
Typically 0.05% topical cream or ointment, applied once or twice daily as directed by a physician |
| Dosage (sports) |
Not applicable as it is not used for performance enhancement |
| Effects |
Reduces inflammation, suppresses immune response, decreases swelling and irritation |
| Formula |
C25H32ClFO5 |
| Half-life |
1.3 hours (biological half-life of topical application) |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
Not typically required in routine use |
| Main action |
Anti-inflammatory |
| Raw Material |
Drostanolone Propionate |
| Side effects |
Skin thinning, adrenal suppression, striae, telangiectasia, perioral dermatitis, hypertrichosis, rosacea |
| Storage conditions |
Store at controlled room temperature, away from light and moisture |
| Substance class |
Corticosteroid |
| Trade name |
Dermovate, Clobex, Temovate, Olux, among others |
| Use in sports |
Not commonly used in sports for performance enhancement, potential use in treating dermatological conditions associated with athletic activities |
| Water Retention |
No |
| Manufacturer |
BETHA PHARMA |
| Packing |
10 ml vial (100 mg/ml) |
